0000950170-23-030218.txt : 20230627 0000950170-23-030218.hdr.sgml : 20230627 20230627175247 ACCESSION NUMBER: 0000950170-23-030218 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230623 FILED AS OF DATE: 20230627 DATE AS OF CHANGE: 20230627 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Heyman Tomas J. CENTRAL INDEX KEY: 0001814673 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38944 FILM NUMBER: 231048685 MAIL ADDRESS: STREET 1: C/O AKERO THERAPEUTICS, INC. STREET 2: 170 HARBOR WAY 3RD FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Akero Therapeutics, Inc. CENTRAL INDEX KEY: 0001744659 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 601 GATEWAY BOULEVARD, SUITE 350 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-487-6488 MAIL ADDRESS: STREET 1: 601 GATEWAY BOULEVARD, SUITE 350 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 ownership.xml 4 X0407 4 2023-06-23 0001744659 Akero Therapeutics, Inc. AKRO 0001814673 Heyman Tomas J. C/O AKERO THERAPEUTICS, INC. 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080 true false false false false Stock Option (Right to Buy) 50.83 2023-06-23 4 A false 15000 0.00 A 2033-06-22 Common Stock 15000 15000 D This option shall vest in full upon the earlier of (i) June 23, 2024 or (ii) the date of the next annual meeting, all vesting shall cease if the director resigns from the Board or otherwise ceases to service as a director. /s/ Jonathan Young, Attorney-in-Fact 2023-06-27